SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference - Seite 2

SMRSC 2024 provided an unparalleled opportunity for participants to explore the future of robotic surgery, with a specific focus on the SSi Mantra. Panel discussions and scientific sessions featured distinguished international faculty, sharing insights on the future of robotic surgery across the world. Sessions also covered the integration of Artificial Intelligence into surgery, and the pursuit of sustainable telesurgery, among others.

The SSi Mantra Surgical Robotic System is the first surgical system to be made in India, and one of the only systems in the world to be cost-effective with broad-spectrum surgical applications including cardiac surgery. It has been granted regulatory approval in India and Guatemala and is clinically validated in more than 40 different types of surgical procedures. More than 650 surgical procedures have been performed using the system to date. SS Innovations has commenced the regulatory approval process in the United States and EU, and anticipates receiving such approvals in the latter half of 2024 -2025 time frame.

For more information about SMRSC, please visit https://www.ssinnovations.com/SMRSC_2024/.

About SS Innovations International, Inc.

SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra”, its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at ssinnovations.com or LinkedIn for updates.

About SSi Mantra

Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 40 different types of surgical procedures. The Company has commenced the regulatory approval process with the US Food and Drug Administration (FDA) and EU authorities, and anticipates receiving such approvals in the latter half of 2024 -2025 time frame.